Shunsuke Sakai Selected Research

Shunsuke Sakai Research Topics

Disease

14	Infections 03/2022 - 06/2007
9	Tuberculosis (Tuberculoses) 01/2021 - 05/2011
4	Neoplasms (Cancer) 01/2021 - 01/2019
4	Thrombosis (Thrombus) 11/2020 - 11/2014
3	Neuroblastoma 01/2020 - 01/2019
2	Myocarditis (Carditis) 01/2022 - 08/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 02/2016
2	Rheumatoid Arthritis 07/2021 - 03/2021
2	Persistent Infection 01/2021 - 01/2021
2	Granuloma 01/2021 - 12/2018
2	Pneumococcal Pneumonia 01/2019 - 06/2014
2	Melanoma (Melanoma, Malignant) 06/2014 - 11/2011
2	Pneumococcal Infections 06/2014 - 11/2011
2	Necrosis 05/2011 - 06/2007
1	Congenital Abnormalities (Deformity) 04/2022
1	COVID-19 03/2022
1	Pneumonia (Pneumonitis) 03/2022
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2022
1	Endometritis 01/2022
1	Hyperthermia 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2021
1	Coronary Stenosis (Coronary Artery Stenosis) 10/2021
1	Pain (Aches) 03/2021
1	Infarction (Infarctions) 08/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 08/2019
1	Communicable Diseases (Infectious Diseases) 01/2019
1	Tuberculoma 01/2019
1	Infertility (Sterility) 08/2018
1	Acute Coronary Syndrome 02/2016
1	Heart Failure 02/2016
1	Stroke (Strokes) 02/2016
1	ST Elevation Myocardial Infarction 11/2014

Drug/Important Bio-Agent (IBA)

4	CytokinesIBA 01/2022 - 09/2009
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2011
4	InflammasomesIBA 01/2019 - 11/2011
3	N-Myc Proto-Oncogene ProteinIBA 01/2020 - 01/2019
3	Peptides (Polypeptides)IBA 01/2020 - 12/2018
3	Interleukin-18 (Interleukin 18)IBA 12/2014 - 11/2011
2	AntigensIBA 03/2022 - 12/2010
2	InterferonsIBA 03/2022 - 01/2019
2	Interleukin-6 (Interleukin 6)IBA 01/2022 - 05/2011
2	Immune Checkpoint InhibitorsIBA 01/2022 - 08/2020
2	omega-Chloroacetophenone (Mace)IBA 10/2021 - 02/2016
2	Programmed Cell Death 1 ReceptorIBA 01/2021 - 01/2019
2	5- (2- oxopropylideneamino)- 6- d- ribitylaminouracilIBA 01/2021 - 01/2021
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2020 - 01/2019
2	Chemokine ReceptorsIBA 09/2019 - 01/2019
2	Oncogene Proteins (Oncogene Protein)IBA 08/2019 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 01/2019
1	Viral RNAIBA 03/2022
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2022
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 01/2022
1	ChemokinesIBA 01/2022
1	Inositol (Myoinositol)IBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	TroponinIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	SteroidsIBA 01/2022
1	LDL Lipoproteins (beta Lipoproteins)IBA 10/2021
1	Malondialdehyde (Propanedial)IBA 10/2021
1	oxidized low density lipoproteinIBA 10/2021
1	Adalimumab (Humira)FDA Link 07/2021
1	Biological ProductsIBA 07/2021
1	Antirheumatic Agents (DMARD)IBA 07/2021
1	Pain-FreeIBA 03/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Caspase 1 (ICE Protease)IBA 01/2021
1	C-Reactive ProteinIBA 11/2020
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 03/2019
1	SolutionsIBA 01/2019
1	TenascinIBA 01/2019
1	EpitopesIBA 12/2018
1	Granzymes (Granzyme)IBA 12/2018
1	Dinoprostone (PGE2)FDA Link 08/2018
1	Interleukin-12 (IL 12)IBA 01/2017
1	Uric Acid (Urate)IBA 02/2016
1	Interleukin-10 (Interleukin 10)IBA 12/2014
1	MetalsIBA 11/2014
1	Pharmaceutical PreparationsIBA 11/2014
1	VaccinesIBA 08/2014
1	Interferon Type IIBA 06/2014
1	Chelating AgentsIBA 02/2014
1	Interferon-betaIBA 07/2012
1	NucleotidesIBA 11/2011
1	Mycobacterium tuberculosis PPE37 proteinIBA 05/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2010
1	LigandsIBA 12/2010
1	Peptide Hydrolases (Proteases)FDA Link 05/2010
1	CalpainIBA 05/2010
1	CalciumIBA 05/2010
1	Interleukin-1alpha (Interleukin 1 alpha)IBA 05/2010

Therapy/Procedure

3	Drug Therapy (Chemotherapy) 03/2021 - 01/2019
3	Therapeutics 01/2021 - 09/2005
3	Stents 11/2020 - 11/2014
2	Immunotherapy 01/2021 - 01/2019
1	Tenodesis 04/2022
1	Oral Administration 03/2019
1	Percutaneous Coronary Intervention 11/2014
1	Drug-Eluting Stents 11/2014